Tram Tran

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Tram Tran

Earlier roles on record: Board Member at Arbutus Biopharma Corp (ABUS) until February 26, 2023. Arbutus Biopharma Corp reported in an 8-K filed January 27, 2023 that Tram Tran resigned as Board of Directors, effective February 26, 2023.

“On January 23, 2023, Tram Tran, M.D. notified Arbutus Biopharma Corporation (the "Company") of her decision to resign from the Board of Directors of the Company and all committees thereof, effective as of February 26, 2023.”

Arbutus Biopharma Corp Form 8-K, filed January 27, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Tram Tran's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Arbutus Biopharma Corp (ABUS)
Board Member

Proxy statement

Start not stated–2023-02-26

Company network

Recorded roles and call appearances connecting this person to public companies.

Arbutus Biopharma Corp

ABUS

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: Board of Directors Arbutus Biopharma Corp (ABUS)
2023-02-26